Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1

Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1

Yoshiro Nakahara,1,2 Yusuke Takagi,1,3 Yukio Hosomi,1 Akiko Kagei,4 Tomohiro Yamamoto,4 Takeshi Sawada,5 Makiko Yomota,1 Yusuke Okuma,1 Shinichiro Mikura,1,6 Tatsuru Okamura1 1Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome...

Full description

Bibliographic Details
Main Authors: Nakahara Y, Takagi Y, Hosomi Y, Kagei A, Yamamoto T, Sawada T, Yomota M, Okuma Y, Mikura S, Okamura T
Format: Article
Language:English
Published: Dove Medical Press 2016-08-01
Series:OncoTargets and Therapy
Subjects:
Circulating tumor DNA
epidermal growth factor receptor (EGFR)
gefitinib
S-1
pemetrexed
Online Access:https://www.dovepress.com/noninvasive-monitoring-of-the-genetic-evolution-of-egfr-mutant-non-sma-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/noninvasive-monitoring-of-the-genetic-evolution-of-egfr-mutant-non-sma-peer-reviewed-article-OTT

Similar Items